A Trojan horse for artificial amino acids

Researchers have modified a bacterial transport system so that it can efficiently introduce large quantities of unnatural amino acids into cells

15-Dec-2025 - Researchers from ETH Zurich have succeeded in introducing large quantities of unnatural amino acids into bacteria, enabling the creation of innovative and highly efficient designer proteins. These can be used as more efficient catalysts or more effective drugs. Life uses 20 amino acid building ...

German pharma company acquires University of Basel start-up for 450 million Swiss francs

New technology uses living bacteria to fight cancer

28-Nov-2023 - The biotech company T3 Pharmaceuticals, a spin-off from the University of Basel, is being acquired by the German pharmaceutical company Boehringer Ingelheim. T3 Pharma has developed a novel technology that uses live bacteria to deliver therapeutic proteins to cancer cells and the tumor ...

Bird’s enzyme points toward novel therapies

Rice University scientists imbue cells with ‘noncanonical’ pathway to make own drugs

21-Sep-2022 - Thank the rarecrested ibisfor a clue that could someday help our bodies make better drugs. The species of bird is the only one known to naturally produce an enzyme able to generate a noncanonicalamino acid; that is, one not among the 20 necessary to encode most proteins. That it exists -- a ...

Platelets as Carriers of Therapeutic Proteins in the Body

Technology opens up a wide range of new therapeutic applications

11-Feb-2022 - Researchers from the Paul-Ehrlich-Institut, together with a research group from the Hannover Medical School, have developed a laboratory model based on lentiviral gene transfer in which therapeutic proteins are targeted to platelets and released in the body. With this newly developed technology, ...

WACKER Strengthens Biologics Business by Acquiring US-Based Plasmid DNA Manufacturer Genopis

Expansion of WACKER's portfolio as a contract manufacturer for the pharmaceutical industry

04-Feb-2021 - The Munich-based chemical company WACKER is acquiring 100 percent of the shares in pharmaceutical contract manufacturer Genopis Inc. from Helixmith Co Ltd, Seoul (South Korea) and Medivate Partners LLC, Seoul (South Korea). WACKER signed a corresponding agreement. WACKER will continue Genopis' ...

Advance Gene Therapy Pipeline for Musculoskeletal Diseases

GeneQuine Biotherapeutics Secures more than €9 Million

28-Jan-2021 - GeneQuine Biotherapeutics GmbH, a biotech company focused on the development of gene therapy for musculoskeletal disorders, announced that it has raised €5.4 million in Series A financing and €3.65 million non-dilutive funding bringing the total amount raised to €9.05 million. The Series A ...

Start-up ViGeneron announces research collaboration with Daiichi Sankyo

Evaluate vgAAV for novel ophthalmic gene therapy

19-Jan-2021 - ViGeneron GmbH, a gene therapy company, announced a research collaboration to utilize its novel engineered adeno-associated virus (vgAAV) vectors with Daiichi Sankyo Company, Limited, for delivering a novel therapeutic protein to address an undisclosed target in a highly prevalent ophthalmic ...

From mirror-image biology to enhanced therapeutic proteins

18-Mar-2019 - Scientists from the German Cancer Research Center (DKFZ) have succeeded in reconstructing biomolecules in their mirror-image form. The researchers' goal is to create a mirror-image artificial protein synthesis system. Their aim is to produce mirror-image therapeutic proteins, such as antibodies, ...

New materials could 'drive wound healing' by harnessing natural healing methods

09-Jan-2019 - Materials are widely used to help heal wounds: Collagen sponges help treat burns and pressure sores, and scaffold-like implants are used to repair bones. However, the process of tissue repair changes over time, so scientists are developing biomaterials that interact with tissues as healing takes ...

Biologists give bacteria thermostat controls

Applications in novel therapeutics for cancer and other diseases

17-Nov-2016 - A new helper in the fight against cancer and other diseases of the gut may be genetically altered bacteria that release medicines to tumors or the gut. Now, a new study performed using mice demonstrates how doctors might one day better regulate those therapeutic microbes by engineering them to ...